India CRDMO Market Size Zooming 2.4X to Surpass USD 53 Billion by 2031

Published | 04 October 2025

India CRDMO (Contract Research, Development, and Manufacturing Organization) Market is booming primarily due to a surging demand for CRDMO services and solutions driven by an increasing focus on cost efficiency and skilled workforce.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated India CRDMO (Contract Research, Development, and Manufacturing Organization) Market size by value at USD 22.61 billion in 2024. During the forecast period between 2025 and 2031, BlueWeave expects India CRDMO Market size to boom at a robust CAGR of 13.10%, reaching a value of USD 53.53 billion by 2031. The rapid expansion of India CRDMO Market is propelled by a rising global demand for integrated drug development solutions, cost-effective manufacturing, and a skilled scientific workforce. The country’s robust infrastructure and favorable regulatory reforms attract international pharmaceutical and biotech firms seeking scalable, high-quality services. Growing interest in advanced modalities like biologics and mRNA therapies further boosts market expansion. Additionally, India’s strategic role in diversifying global supply chains amid geopolitical shifts enhances its appeal as a reliable partner for end-to-end research, development, and manufacturing operations.

Opportunity – Expansion into Biologics and RNA Therapeutics

India CRDMO Market is rapidly expanding into biologics and RNA therapeutics, driven by a global demand for advanced treatment modalities. Domestic firms are investing in high-end infrastructure, GMP-compliant facilities, and specialized talent to support monoclonal antibodies, biosimilars, and mRNA platforms. This shift enhances India’s value proposition beyond small molecules, attracting global biotech collaborations. As precision medicine and next-generation therapies gain momentum, India’s biologics and RNA capabilities position it as a competitive, scalable partner in the global drug development ecosystem.

Sample Request: https://www.blueweaveconsulting.com/report/india-crdmo-market/report-sample

Manufacturing Services Dominate India CRDMO Market ​

Manufacturing services constitute the largest segment of India CRDMO Market, driven by the country’s strong capabilities in large-scale production, cost efficiency, and regulatory compliance. Indian CRDMOs are widely recognized for their expertise in small molecule synthesis, API production, and formulation development. The segment benefits from robust infrastructure, skilled labor, and strategic partnerships with global pharmaceutical firms. As demand for scalable, high-quality manufacturing solutions grows, India’s dominance in the manufacturing segment continues to expand, reinforcing its role in global drug supply chains.

Impact of Escalating Geopolitical Tensions on India CRDMO Market 

Escalating geopolitical tensions across the regions could disrupt pharmaceutical supply chains, delay cross-border drug approvals, and hinder clinical research collaborations. Trade restrictions and regulatory uncertainties may affect the flow of CRDMO contracts. Additionally, diverted the government’s focus and funding toward defense can reduce investments in public health initiatives. These challenges pose risks to consistent access, affordability, and innovations in India CRDMO Market, potentially slowing market growth despite rising demand for effective treatment across vulnerable populations.

Competitive Landscape

India CRDMO Market is highly fragmented, with numerous players serving the market. Major companies dominating the market are Syngene International, Jubilant Biosys, Piramal Pharma Solutions, Dr. Reddy’s Laboratories, GVK Biosciences, Sai Life Sciences, Aragen Life Sciences, Anthem Biosciences, TCG Lifesciences, Laurus Labs, and Divi’s Laboratories. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge over their competitors in India CRDMO Market.

Don’t miss the business opportunity in India CRDMO Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The report's in-depth analysis provides information about growth potential, upcoming trends, and India CRDMO Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in India CRDMO Market, along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Scope of the Report

About Us

BlueWeave Consulting provides all-inclusive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing qualitative and quantitative data to boost your business solution's performance. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are a promising digital MI solutions company providing agile assistance to make your business endeavors successful.

Contact Us:

BlueWeave Consulting & Research Pvt Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

info@blueweaveconsulting.com